5Esteves K.Safety of oral poliomyelitis vaccine:results of a WHO enquiry[J].Bull WHO,1988,66(6):739-746.
6Andrus JK,Strebel PM,de Quadros CA,et al.Risk of Vaccine associated paralytic poliomyelitisin Latin America,1988-1991[J].Bull WHO,1995,73(1):33-40.
7CDC.Circulation of a type 2 vaccine-derived poliovirus-Egypt,1982-1993[J].MMWR,2001,50(3):41-42.
8Update.OPV-derived poliomyelitis outbreak in the Dominican republic and Hait[J].EPI Newsletter,2001,23(1):4-5.
9Update.Vaccine derived polio outbreak in Hispaniola[J].EPI Newsletter,2001,23 (3):3-4.
10Strebel PM,Nedelcu IN,Banghman AL,et al.Intramuscular Injections with 30 Days of Immunization with Oral poliovirus Yaecine-A Risk for Vaccine-Associated Paralytic Poliomyelitis[J].N Engl J Med,1995,332:500.
2Shohreh Shahmahmood, Nina Parraneh, Cara Bams. Isolation of a type- 3 vaccine- derived (VDPV) from an Iranian child whth X-linked agam- maglobulinemia[J].Virus Research.2008,137(1): 168-172.
